Sanctuary Sleep Mask
Sanctuary integrates bioverà’s upstream respiratory intelligence into a soft, comfortable sleep mask designed for overnight use. It provides continuous real time sensing and gentle intervention to address snoring, irregular airflow, and early apnea events while preserving natural sleep architecture and user comfort.
bioverà.ai, An Upstream Respiratory Intelligence Platform
A New Class of Non-Invasive Respiratory Intelligence
bioverà is a patent-pending upstream respiratory intelligence platform designed to sense, interpret, and modulate human breathing in real time.
The platform is expressed through multiple wearable embodiments, including Upstream, Sanctuary, RespiVision, RespiGo, RespiHelmet, and G-LOC, each built around the same core upstream architecture.
bioverà is developed for licensing, strategic partnerships, and advanced applications across sleep health, performance, safety, and defense. The platform integrates sensing, adaptive response, and non-invasive modulation within discreet, form-factor-agnostic wearables.
Upstream and downstream respiratory care
bioverà operates upstream in the respiratory care continuum. While therapies such as CPAP are highly effective for advanced sleep disordered breathing, a much larger population exists earlier where breathing instability and airflow restriction first appear.
bioverà senses breathing patterns in real time and applies gentle, non invasive sensory stimulation to support more stable airflow before conditions escalate. This upstream approach is designed to complement downstream therapies and integrate within existing sleep and respiratory ecosystems.
Conceptual illustration shown. bioverà is not intended to diagnose, treat, or replace medical therapies.
Market scale and reach
The global sleep and respiratory care market exceeds 40 billion annually, driven by widespread snoring, sleep disordered breathing, and rapid adoption of connected and AI enabled health technologies.
An estimated 900 million adults worldwide experience some form of sleep disordered breathing, the majority of whom are untreated, undiagnosed, or not yet indicated for downstream therapies such as CPAP.
bioverà is designed to address this large upstream population by providing a licensable respiratory intelligence layer that complements existing downstream therapies and expands earlier intervention opportunities.